I-131 METAIODOBENZYLGUANIDINE SCINTIGRAPHY FOR THE LOCATION OF NEURO-BLASTOMA - PRELIMINARY EXPERIENCE IN 10 CASES
- 1 January 1985
- journal article
- research article
- Vol. 26 (7) , 736-742
Abstract
Ten patients with histologically proven neuroblastoma were studied by [131I]MIBG [metaiodobenzylguanidine] scintigraphy. Tumor uptake of the radiopharmaceutical showed a spectrum varying from no uptake to 1 case, to slight uptake in 2, moderate uptake in 2 and intense uptake in 5 cases. [131I]MIBG scintigraphy was more effective in demonstrating the extent of neuroblastoma spread than were conventional bone scan and CT [computed tomography] in 1 patient, equal to these modalities in 4 cases, almost equal in 2 cases and significantly inferior in 3 cases. [131I]MIBG scintigraphy is useful in detecting the presence and delineating the distribution of neuroblastoma and may, in certain cases, have therapeutic potential.This publication has 6 references indexed in Scilit:
- The location of middle mediastinal pheochromocytomasThe Journal of Thoracic and Cardiovascular Surgery, 1984
- MALIGNANT PHAEOCHROMOCYTOMA: CLINICAL, BIOCHEMICAL AND SCINTIGRAPHIC CHARACTERIZATIONClinical Endocrinology, 1984
- RADIOPHARMACEUTICAL TREATMENT OF MALIGNANT PHEOCHROMOCYTOMA1984
- Recurrent neuroblastoma: the role of CT and alternative imaging tests.Radiology, 1983
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981
- Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamineLife Sciences, 1977